Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 25, 2011

View Archived Issues

New cDNA library vaccine cures experimental prostate cancer

Plant-produced protein blocks transmission of Plasmodium falciparum

Investigation of thiostrepton uncovers new possible target for breast cancer therapy

Taisho synthesizes new vasopressin V1B receptor antagonists

KalVista receives funding to develop new treatment for diabetic macular edema

Merck & Co. presents novel Lck inhibitors

Spinifex Pharmaceuticals obtains funding to expand phase II EMA-401 program

Novacta Biosystems discloses novel lantibiotic-based agents

Chinese company prepares novel tyrosine-protein kinase inhibitors

Pharmaneuroboost receives IRB approval for phase III PNB-01 trial

Theron Pharmaceuticals patents novel muscarinic acetylcholine M3 receptor antagonists

FDA awards fast track status to Pharmasset's PSI-938

Allergan prepares novel prostanoid EP2 receptor agonists

Phase III study of treprostinil diethanolamine does not meet primary endpoint

Clavis Pharma expands pivotal phase III elacytarabine trial

FDA approves Botox for new indication

RegeneRx completes enrollment in phase II dry eye syndrome study

Pharmaxis resubmits data for E.U. Bronchitol marketing application

FDA issues communication regarding high doses of citalopram

Peregrine reports survival data from bavituximab plus docetaxel breast cancer study

NICE issues recommendation regarding golimumab

SIGA receives NIH grant to develop antiviral drug

Senesco Technologies and Mayo Clinic finalize agreement to study SNS01-T

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...